Cross-sectional study of drug use in pregnancy;Presjecňo istraživanje (cross-sectional study) uporabe lijekova u trudnoći

Lijecnicki Vjesnik

Volumn 129, Issue 8-9, 2007, Pages 253-259

  Ĉulig, Josip ^a,f   Leppée, Marcel ^a   Ŝtimac, Danijela ^a   Kuvaĉić, Ivan ^b   Pulanič Klepac, Tajana ^b   Herman, Radoslav ^c   Tučkar, Neven ^c   Podobnik, Mario ^d   Klobučar, Ante ^e   Mateša, Sanja ^e   Polić Vižintin, Marina ^a   Damić, Andrija Mišo ^a  

^a Zavod za Javno Zdravstvo Grada Zagreba ^*  (Croatia)

^b KBC Zagreb   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d University of Zagreb   (Croatia)

^e Klinika za Ginekologiju i Porodiljstvo OB Sveti Duh

^f Zagreb Institute of Public Health   (Croatia)

Author keywords

Cross sectional studies; Drug utilization statistics and numerical data; Pregnancy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROATIA; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; QUESTIONNAIRE;

ADOLESCENT; ADULT; CROATIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; QUESTIONNAIRES;

EID: 36549003147     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Malm H, Matikainen J, Klaukka T, Neuvonen P.J. Prescription drugs during pregnancy and lactation - a Finnish register-based study. Eur J Clin Pharmacol 2003;59:127-33.
2. De Vigan C, De Walle HEK, Cordier S i sur. OECM Working Group. Therapeutic drug use during pregnancy: a comparison in four European countries. J Clin Epidemiol 1999;52:977-82.
3. Collaborative group on drug use in pregnancy (CGDUP). Medication during pregnancy: an intercontinental cooperative study. Int J Gynecol Obstet 1992;39:185-96.
4. Egen-Lappe V, Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004;60:659-66.
5. Bonati M, Bortolus K, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990;38:325-8.
6. Marchetti F, Romero M, Bonati M, Tognoni G and the Collaborative Group on Drug Use in Pregnancy (CGDUP). Use of psyhotropic drugs during pregnancy. Eur J Pharmacol 1993;45:495-501.
7. Piper JM, Baum C, Kennedy DL. Prescription drug use before and during pregnancy in a population. Am J Obstet Gynecol 1987;157:148-56.
8. Andrade SE, Gurwitz JH, Davis RL i sur. Prescription use in pregnancy. Am J Obstet Gynecol 2004;191:398-407.
9. Riley EH, Fuentes-Afflick E, Jackson RA i sur. Correlates of prescription drug use during pregnancy. J Womens Health 2005;14:401-9.
10. Hoffmann A, Jager O, Peiker G, Reimann I. Drug use in pregnancy: East German data of an international collaborative study. Int J Clin Pharmacol Ther Toxicol 1992;30:462-4.
11. Reimann I, Karpinsky C, Hoffmann A. Epidemiological data on drug use during pregnancy in Thuringia, East Germany. Int J Clin Pharmacol Ther 1993;34:80-3.
12. Irl C, Hasford J, and the PEGASUS-Study Group. The PEGASUS project - a perspective cohort study for the investigation of drug use in pregnancy. Int J Clin Pharmacol Ther 1997;35:572-6.
13. Egen V, Roesch C, Steinbicker V, Hasford J. Drug utilization during pregnancy - a comparison between East and West Germany. Pharmacoepidemiol Drug Saf 2002;11:S148-S9.
14. Perinatology.com. Drugs in Pregnancy and Breastfeeding. FDA categories. http://www.perinatology.com/exposures/druglist.htm
15. Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). WHO Collaborating Centre for Drug Statistic Methodology Oslo 2005.
16. Bulat M, Geber J, Lacković Z. Medicinska farmakologija. Zagreb: Medicinska naklada; 1999.
17. Živković R. Klinička farmakologija. Zagreb: Medicinska naklada; 2000.
18. Vrhovac B. i sur. Farmakoterapijski priručnik. Zagreb: Medicinska naklada; 2003.
19. Kunec-Vajić E. Farmakokinetika. Zagreb: Medicinska naklada; 2004.
20. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 2. izd. Baltimore: Williams & Wilkins; 1998.
21. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastmc JL. Prescription of drugs during pregnancy in France. Lancet 2000;356(9243):1735-6.
22. De Jong-van den Berg LTW, van den Berg PB, Haaijer-Ruskamp FM, Dukes MNG, Wesseling H. Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl (Sci) 1991;13:32-8.
23. Mirkin BL. Perinatal pharmacology and therapeutics. New York: Academic Press; 2003.
24. Oslen C, Sorensen HT, de Jong-van den Berg L, Oslen J, Steffemen FH. Prescribing during pregnancy and lactation with reference to Swedish classification system. A population-based study among Danish women. The Euromap Group. Acta Obstet Gynecol Scand 1999;78(8):686-92.
25. Oslen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Oslen J, Sorensen HT. Drug use in first pregnancy and lactation: a population based survey among Danish women. The EUROMAP Group. Eur J Clin Pharmacol 1999;55(29):139-44.
26. Van Rooij IA, Ocke MC, Straatman H, Zielhuis GA, Merkus HM, Steegers-Theunissen RP. Periconceptional folate intake by supplement and food reduces the risk of nonsyndromic cleft lip with or without clef palate. Prev Med 2004;39(4):689-94.
27. Pitkin RM. Folate and neural tube defects. Am J Clin Nutr 2007;1:285S-288S.
28. Czeizel AE. Folic acid: a public-health challenge. Foundation for the Community Control of Hereditary Diseases, Budapest.
29. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006;28(8):680-9.
30. Jackson AA, Robinson SM. Dietary guidelines for pregnancy: a review of current evidence. Public Health Nutr 2001;4 (2B):625-30.
31. Kind KL, Moore VM, Davies MJ. Diet around conception and during pregnancy- effects on fetal and neonatal outcomes. Reprod Biomed 2006;12(5):532-41.
32. Glenville M. Nutritional supplements in pregnancy: commercial push or evidence based? Curr Opin Obstet Gynecol 2006;18(6):642-7.
33. Štimac D, Vukušić I, Čulig J i sur. Izvanbolnička potrošnja lijekova u gradu Zagrebu u 2002. i 2003. godini. Pharmaca 2004;42:174-89.
34. Iqbal MM, Sobhan T, Aftab SR, Mahmud SZ. Diazepam use during pregnancy: a review of the literature. Del Med J 2002;74(3):127-35.
35. Guidelines for the clinical evaluation of psychoactive drugs in infants and children, US Dept. Hlth. Education and Welfare. Washington: FDA 79-3055; 1979.
36. Einarson A, Vega CP. The safety of psychotropic drug use during pregnancy: a review. Med Gen Med 2005;7(4):3.
37. Ibanez L, Vidal X, Ballarin E i sur. Population-based drug-induced agranulocytosis. Arch Intern Med 2005;165:869-74.
38. Backstrom M, Hagg S, Mjorndal T i sur. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiol Drug Saf 2002;11:239-45.
39. Ibanez L, Vidal X, Ballarin E i sur. Agranulocytosis associated with dipyrone (metamizole). Eur J Clin Pharmacol 2005;60:821-9.
40. http://www.euro.who int./Document/E88101.pdf